Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
6.56
+0.33 (5.30%)
At close: Feb 3, 2026, 4:00 PM EST
6.75
+0.19 (2.90%)
After-hours: Feb 3, 2026, 7:58 PM EST
Sagimet Biosciences Market Cap
Sagimet Biosciences has a market cap or net worth of $213.34 million as of February 3, 2026. Its market cap has increased by 55.19% in one year.
Market Cap
213.34M
Enterprise Value
87.96M
1-Year Change
55.19%
Ranking
Category
Stock Price
$6.56
Market Cap Chart
Since the IPO on July 14, 2023, Sagimet Biosciences's market cap has decreased from $354.80M to $213.34M, a decrease of -39.87%. That is a compound annual growth rate of -18.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 2, 2026 | 202.61M | 5.24% |
| Dec 31, 2025 | 192.53M | 32.89% |
| Dec 31, 2024 | 144.88M | 16.75% |
| Dec 29, 2023 | 124.10M | -65.02% |
| Jul 14, 2023 | 354.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Silence Therapeutics | 228.61M |
| Protalix BioTherapeutics | 222.36M |
| Context Therapeutics | 222.35M |
| Voyager Therapeutics | 221.84M |
| Achieve Life Sciences | 220.92M |
| Nuvectis Pharma | 220.42M |
| Tonix Pharmaceuticals Holding | 219.64M |
| Alector | 218.30M |